CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma

This publication has 24 references indexed in Scilit:

• RETRACTED ARTICLE: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells
  Oncogene, 2004
• Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance
  Journal of Clinical Oncology, 2003
• Involvement of Gangliosides in Glycosylphosphatidylinositol-anchored Neuronal Cell Adhesion Molecule TAG-1 Signaling in Lipid Rafts
  Journal of Biological Chemistry, 2000
• Immunotoxins in cancer therapy
  Current Opinion in Immunology, 1999
• Saporin, a ribosome‐inactivating protein used to prepare immunotoxins, induces cell death via apoptosis
  British Journal of Haematology, 1996
• Ribosome-inactivating proteins from plants
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
• Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation
  British Journal of Cancer, 1993
• Antibody By 114 is selective for the 90 kD PI‐linked component of the CD66 antigen: a new reagent for the study of paroxysmal nocturnal haemoglobinuria
  British Journal of Haematology, 1993
• New Indirect Approach to the Therapeutic Use of Immunotoxins
  JNCI Journal of the National Cancer Institute, 1988
• The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: The RNA N-glycosidase activity of the proteins
  Biochemical and Biophysical Research Communications, 1988